Last reviewed · How we verify
NCT05626205: PARO
Psycho-social Intervention With Paro Robotic Seal Focused on Patients With Dementia
NA trial testing PARO robot in Alzheimer Disease in 20 participants. Status unknown.
30 March 2024
Quick facts
| Lead sponsor | Istituto Nazionale di Ricovero e Cura per Anziani |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 5 November 2022 |
| Primary completion | 30 March 2024 |
| Estimated completion | 30 March 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- PARO robot
Conditions studied
- Alzheimer Disease — all drugs for Alzheimer Disease →
- Older Adults — all drugs for Older Adults →
Sponsor
Istituto Nazionale di Ricovero e Cura per Anziani — full company profile →
Who can join
65 and older, any sex, with Alzheimer Disease or Older Adults. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall objective of the study is to evaluate the improvement in patient-perceived quality of life following the use of the Paro robot integrated with traditional intervention in the elderly with dementia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Social robotics to support older people with dementia: a study protocol with Paro seal robot in an Italian Alzheimer's day center.
Bevilacqua R, Maranesi E, Felici E, Margaritini A, et al · · 2023 · cited 5× · PMID 37415712 · DOI 10.3389/fpubh.2023.1141460
Verify or expand the search:
- PubMed search for NCT05626205
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alzheimer Disease
Currently open trials in the same condition.
- NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
- NCT07178210 — Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease · NA · recruiting
- NCT07294885 — Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease · NA · recruiting
- NCT06937229 — A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · recruiting
- NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting
Other Istituto Nazionale di Ricovero e Cura per Anziani trials
Trials by the same sponsor.
- NCT06984393 — Tele-Rehabilitation Intervention in Community-Based Healthcare for Patients With Parkinson's Disease (DHEAL-COM-PD) · NA · not yet recruiting
- NCT06984380 — Tele-Rehabilitation Intervention in Community-Based Healthcare for Patients With Osteoporosis (DHEAL-COM-OP) · NA · not yet recruiting
- NCT07435467 — Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline an · recruiting
- NCT06984367 — A Socio-Technological Intervention in Community-Based Healthcare for Individuals With Mild Cognitive Impairment (DHEAL-C · NA · recruiting
- NCT07002411 — Hospitality Oriented Service Perception Evolution With Robots (HOSPER) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05626205 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istituto Nazionale di Ricovero e Cura per Anziani
- Last refreshed: 5 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05626205.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing